Applied Biomath highlights presentations at SITC meeting

By The Science Advisory Board staff writers

November 4, 2021 -- Applied Biomath is highlighting two poster presentations being offered at the upcoming Society for Immunotherapy of Cancer (SITC) meeting in Washington, DC.

Company principal scientist David Flowers, PhD, will present a poster titled, "A Computational Semimechanistic Pharmacology Model of ATG-101, a PD-L1/4-1BB Bispecific Antibody for Treatment of Solid Tumors." The work describes the company's collaboration with Antengene on the development of a systems pharmacology model for understanding the treatment's tumor-killing mechanism.

A second poster presentation describes results of the company's collaboration with Genmab and is titled, "Dose Selection for DuoBody-PD-L1×4-1BB (GEN1046) Using a Semimechanistic Pharmacokinetics/Pharmacodynamics Model That Leverages Preclinical and Clinical Data."

The SITC meeting will be held November 10-14, 2021.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.